Impact of Manual and Automated Interpretation of Fused PET/CT Data on Esophageal Target Definitions in Radiation Planning

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 5, 2008, Pages 1612-1618

  Hong, Theodore S ^a   Killoran, Joseph H ^b   Mamede, Marcelo ^c   Mamon, Harvey J ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NONE

Author keywords

Esophageal cancer; PET CT; radiation therapy; treatment planning

Indexed keywords

ELECTRIC INSTRUMENT TRANSFORMERS; POSITRON EMISSION TOMOGRAPHY;

AUTOMATED INTERPRETATIONS; ESOPHAGEAL CANCER; ESOPHAGEAL CANCERS; GROSS TUMOR VOLUMES; LYMPH NODES; NODAL REGIONS; PET/CT; RADIATION PLANNING; RADIATION THERAPY; SEMI AUTOMATED; TARGET DEFINITIONS; TREATMENT PLANNING; TUMOR VOLUMES;

TUMORS;

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT PLANNING; TUMOR VOLUME;

AUTOMATION; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; THORACIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 56349094350     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.07.061     Document Type: Article

References (23)

1. Tepper J., Krasna M.J., Niedzwiecki D., et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26 (2008) 1086-1092
2. Urba S.G., Orringer M.B., Turrisi A., et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19 (2001) 305-313
3. Walsh T.N., Noonan N., Hollywood D., et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335 (1996) 462-467
4. Herskovic A., Martz K., al-Sarraf M., et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326 (1992) 1593-1598
5. Minsky B.D., Pajak T.F., Ginsberg R.J., et al. INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol 20 (2002) 1167-1174
6. X-s G., Qiao X., Wu F., et al. Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma. Int J Radiat Oncol Biol Phys 67 (2007) 389-396
7. Lam K.Y., Ma L.T., and Wong J. Measurement of extent of spread of oesophageal squamous carcinoma by serial sectioning. J Clin Pathol 49 (1996) 124-129
8. Flamen P., Lerut A., Van Cutsem E., et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 18 (2000) 3202-3210
9. Katsoulis I.E., Wong W.L., Mattheou A.K., et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: A prospective study. Int J Surg 5 (2007) 399-403
10. Konski A., Doss M., Milestone B., et al. The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 1123-1128
11. Liberale G., Van Laethem J.L., Gay F., et al. The role of PET scan in the preoperative management of oesophageal cancer. [see comment]. Eur J Surg Oncol 30 (2004) 942-947
12. Malik V., Keogan M., Gilham C., et al. FDG-PET scanning in the management of cancer of the oesophagus and oesophagogastric junction: Early experience with 100 consecutive cases. Irish J Med Sci 175 (2006) 48-54
13. Meyers B.F., Downey R.J., Decker P.A., et al. The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: Results of the American College of Surgeons Oncology Group Z0060 trial. J Thor Cardiovasc Surg 133 (2007) 738-745
14. Sihvo E.I., Rasanen J.V., Knuuti M.J., et al. Adenocarcinoma of the esophagus and the esophagogastric junction: Positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease. J Gastroint Surg 8 (2004) 988-996
15. Stahl A., Stollfuss J., Ott K., et al. FDG PET and CT in locally advanced adenocarcinomas of the distal oesophagus. Clinical relevance of a discordant PET finding. Nuclearmedizin 44 (2005) 249-255 quiz N255-246
16. Moureau-Zabotto L., Touboul E., Lerouge D., et al. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. Int J Radiat Oncol Biol Phys 63 (2005) 340-345
17. Moureau-Zabotto L., Touboul E., Lerouge D., et al. [Impact of computed tomography (CT) and 18F-deoxyglucose positron emission tomography (FDG-PET) image fusion for conformal radiotherapy in esophageal carcinoma]. Cancer Radiotherapie 9 (2005) 152-160
18. Gondi V., Bradley K., Mehta M., et al. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 67 (2007) 187-195
19. Mamede M., Fakhri G.E., Abreu-e-Lima P., et al. Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation. Ann Nucl Med 21 (2006) 553-562
20. Nestle U., Kremp S., Schaefer-Schuler A., et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer. J Nucl Med 46 (2005) 1342-1348
21. Nestle U., Kremp S., and Grosu A.-L. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC) The technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 81 (2006) 209-225
22. Gondi V., Bradley K., Mehta M., et al. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 67 (2007) 187-195
23. Heron DE, Andrade RS, Flickinger J, et al. Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: A brief technical report. Int J Radiat Oncol Biol Phys 1419;60:1419-1424.